Dermatomyositis as the first manifestation of gallbladder adenocarcinoma: case report and literature overview.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
vasculitis 1 rheumatologydiseases
dermatomyositis 10 rheumatologydiseases
methylprednisolone 2 rheumatologydiseasesdrugs
myopathy 1 rheumatologydiseases
myositis 13 rheumatologydiseases
prednisolone 2 rheumatologydiseasesdrugs

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
methylprednisolone 5263 Prior to starting chemotherapy in March 2014, the dermatologist increased the corticosteroid dosage ( methylprednisolone 60 mg/day) due to newly manifested periorbital edema and macular exanthem in the regions of the trunk,
methylprednisolone 6286 with periorbital edema more pronounced on the left side, despite the 32 mg/day maintenance dose of methylprednisolone . A follow-up MSCT of the abdomen showed a 12-mm thickening of the cholecyst wall - a regression, compared
prednisolone 5269 to starting chemotherapy in March 2014, the dermatologist increased the corticosteroid dosage (methyl prednisolone 60 mg/day) due to newly manifested periorbital edema and macular exanthem in the regions of the trunk,
prednisolone 6292 periorbital edema more pronounced on the left side, despite the 32 mg/day maintenance dose of methyl prednisolone . A follow-up MSCT of the abdomen showed a 12-mm thickening of the cholecyst wall - a regression, compared
Select Disease Character Offset Disease Term Instance
dermatomyositis 518 proximal muscle weakness. In this paper, I will present the case of a 48-year-old female patient whose dermatomyositis was initially diagnosed as vasculitis. Following the patient’s inadequate response to corticosteroid
dermatomyositis 801 showing inoperable gallbladder adenocarcinoma. Although initial chemotherapy led to regression, the dermatomyositis developed an independent course with new pathological changes leading to the progression of the disease.
dermatomyositis 1070 in English published so far. Gallbladder carcinoma should be added to the list of malignancies with dermatomyositis and has to be excluded by relevant investigation in women.BackgroundDermatomyositis (DM) is an uncommon
dermatomyositis 8313 and although she did not test positive for autoantibodies usually present in patients suffering from dermatomyositis , it is my opinion that her clinical presentation is consistent with paraneoplastic dermatomyositis.
dermatomyositis 8412 dermatomyositis, it is my opinion that her clinical presentation is consistent with paraneoplastic dermatomyositis . The patient underwent chemotherapy with cisplatin and gemcitabine, which was in accordance with the
dermatomyositis 9415 treatment.In January 2015, I searched PubMed for terms gallbladder cancer, gallbladder carcinoma and dermatomyositis and found a total of six case reports in English describing dermatomyositis in patients suffering from
dermatomyositis 9491 gallbladder carcinoma and dermatomyositis and found a total of six case reports in English describing dermatomyositis in patients suffering from gallbladder carcinoma [[9]-[13]]. All of the cases featured female patients
dermatomyositis 9742 present risk factors (previously verified gallstones). The time interval between the appearance of dermatomyositis and malignant disease ranged from 2 weeks to 2 years. Considering the patient was initially treated
dermatomyositis 10650 a complete regression of skin changes following adequate treatment, in the case of my patient, the dermatomyositis and the malignant disease progressed independently of one another [[13]]. Following high-dose corticosteroid
dermatomyositis 11100 regression of the disease.ConclusionsGall bladder carcinoma should be added to the list of malignancies with dermatomyositis and has to be excluded by relevant investigation in women, especially since an inexpensive, simple and
myopathy 1203 excluded by relevant investigation in women.BackgroundDermatomyositis (DM) is an uncommon inflammatory myopathy characterized by pain and weakness in the proximal muscles and cutaneous manifestations. The skin findings
myositis 48 Title: World Journal of Surgical OncologyDermato myositis as the first manifestation of gallbladder adenocarcinoma: case report and literature overviewPetra JurcicPublication
myositis 282 (epub): 3/2015Publication date (pmc-release): 3/2015Publication date (collection): /2015AbstractDermato myositis (DM) is characterized by pathognomic cutaneous manifestations (heliotrope rash, periorbital edema, Gottron’s
myositis 525 muscle weakness. In this paper, I will present the case of a 48-year-old female patient whose dermato myositis was initially diagnosed as vasculitis. Following the patient’s inadequate response to corticosteroid
myositis 808 inoperable gallbladder adenocarcinoma. Although initial chemotherapy led to regression, the dermato myositis developed an independent course with new pathological changes leading to the progression of the disease.
myositis 1077 English published so far. Gallbladder carcinoma should be added to the list of malignancies with dermato myositis and has to be excluded by relevant investigation in women.BackgroundDermatomyositis (DM) is an uncommon
myositis 1161 malignancies with dermatomyositis and has to be excluded by relevant investigation in women.BackgroundDermato myositis (DM) is an uncommon inflammatory myopathy characterized by pain and weakness in the proximal muscles
myositis 8320 although she did not test positive for autoantibodies usually present in patients suffering from dermato myositis , it is my opinion that her clinical presentation is consistent with paraneoplastic dermatomyositis.
myositis 8419 dermatomyositis, it is my opinion that her clinical presentation is consistent with paraneoplastic dermato myositis . The patient underwent chemotherapy with cisplatin and gemcitabine, which was in accordance with the
myositis 9422 treatment.In January 2015, I searched PubMed for terms gallbladder cancer, gallbladder carcinoma and dermato myositis and found a total of six case reports in English describing dermatomyositis in patients suffering from
myositis 9498 gallbladder carcinoma and dermatomyositis and found a total of six case reports in English describing dermato myositis in patients suffering from gallbladder carcinoma [[9]-[13]]. All of the cases featured female patients
myositis 9749 present risk factors (previously verified gallstones). The time interval between the appearance of dermato myositis and malignant disease ranged from 2 weeks to 2 years. Considering the patient was initially treated
myositis 10657 complete regression of skin changes following adequate treatment, in the case of my patient, the dermato myositis and the malignant disease progressed independently of one another [[13]]. Following high-dose corticosteroid
myositis 11107 the disease.ConclusionsGall bladder carcinoma should be added to the list of malignancies with dermato myositis and has to be excluded by relevant investigation in women, especially since an inexpensive, simple and
vasculitis 561 will present the case of a 48-year-old female patient whose dermatomyositis was initially diagnosed as vasculitis . Following the patient’s inadequate response to corticosteroid treatment, clinical and radiologic

You must be authorized to submit a review.